Skip to Main Content

Author Details

Andrew B Waight
Merck & Co.
2003
20
12
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35727687Codon Optimization Using a Recurrent Neural Network.J Comput Biol2023
37610144A machine learning strategy for the identification of key <i>in silico</i> descriptors and prediction models for IgG monoclonal antibody developability properties.MAbs2023
35133949BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning.MAbs2022
35076451Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability.Antibodies (Basel)2022
35240221ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern.Antiviral Res2022
33369163Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation.ChemMedChem2021
33288628Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models.Mol Cancer Ther2021
32527543Structure-activity relationships of tubulysin analogues.Bioorg Med Chem Lett2020
30242091Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug Conjugates.Mol Cancer Ther2018
29866744Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR<sup>+</sup> and Heterogeneous Tumor Models.Mol Cancer Ther2018
26944920Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates.Mol Cancer Ther2016
27395016Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation.J Mol Biol2016
27518442Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics.PLoS One2016
27078104Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides.Proc Natl Acad Sci U S A2016
25187564A previously undescribed tubulin binder.Proc Natl Acad Sci U S A2014
23542591Crystal structure of a eukaryotic phosphate transporter.Nature2013
23685453Structural basis for alternating access of a eukaryotic calcium/proton exchanger.Nature2013
23773802Ion selectivity and gating mechanisms of FNT channels.Curr Opin Struct Biol2013
20010838Structure and mechanism of a pentameric formate channel.Nat Struct Mol Biol2010
12733877Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tethering.J Am Chem Soc2003
  • 1 - 20 of 20

Recommended Authors

Stanford University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
University of California san francisco
Career Start Year 2015
Number of shared co-authors 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 0
The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 1
ShanghaiTech University, China iHuman Institute
Career Start Year 2006
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2002
Number of shared co-authors 1
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
MedImmune Ltd.
Career Start Year 2001
Number of shared co-authors 1
Incyte Corporation
Career Start Year 2000
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 2
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 1
Diamond Light Source Ltd, Harwell Science & Innovation Campus
Career Start Year 1998
Number of shared co-authors 1
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 2
Oncology R&D
Career Start Year 1997
Number of shared co-authors 1
Lilly Research Laboratories
Career Start Year 1994
Number of shared co-authors 1
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1994
Number of shared co-authors 1
The Walter and Eliza Hall Institute of Medical Research
Career Start Year 1993
Number of shared co-authors 1
Bridge Institute, University of Southern California
Career Start Year 1991
Number of shared co-authors 0
Heidelberg University
Career Start Year 1989
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 3
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 1
iHuman Institute, ShanghaiTech University
Career Start Year 1988
Number of shared co-authors 3
Boston University
Career Start Year 1987
Number of shared co-authors 0
Institute of Pharmaceutical Chemistry, Goethe University
Career Start Year 1983
Number of shared co-authors 1
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 1
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 1

Collaborators

Aarhus University
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 2
Institut Pasteur, Universite Paris Cite, CNRS UMR 8
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Pfizer Inc.
Co-authored papers 2
University of California san francisco
Co-authored papers 1
Sher-i-Kashmir Institute of Medical Sciences
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Jawaharlal Nehru University
Co-authored papers 1
Co-authored papers 1